{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:08:09Z","timestamp":1753272489629,"version":"3.40.5"},"reference-count":20,"publisher":"American Academy of Pediatrics (AAP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"DOI":"10.1542\/pir.2021-005020","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T03:03:34Z","timestamp":1664593414000},"page":"582-585","source":"Crossref","is-referenced-by-count":1,"title":["Leukocytosis in the Newborn"],"prefix":"10.1542","volume":"43","author":[{"given":"Mahvish Q.","family":"Rahim","sequence":"first","affiliation":[{"name":"*Department of Pediatrics"},{"name":"\u2020Division of Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn D.","family":"Lajiness","sequence":"additional","affiliation":[{"name":"*Department of Pediatrics"},{"name":"\u2021Division of Neonatal-Perinatal Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Saraf","sequence":"additional","affiliation":[{"name":"*Department of Pediatrics"},{"name":"\u2020Division of Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riddhi","family":"Shukla","sequence":"additional","affiliation":[{"name":"*Department of Pediatrics"},{"name":"\u2021Division of Neonatal-Perinatal Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca S.","family":"Rose","sequence":"additional","affiliation":[{"name":"*Department of Pediatrics"},{"name":"\u2021Division of Neonatal-Perinatal Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"issue":"2","key":"2022102615543322500_B1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1309\/XREF-C9T2-6U0A-4EDT","article-title":"Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome: an immunophenotypic analysis","volume":"116","author":"Karandikar","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2022102615543322500_B2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bjh.12041","article-title":"Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder","volume":"159","author":"Gamis","year":"2012","journal-title":"Br J Haematol"},{"issue":"1-2","key":"2022102615543322500_B3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1615\/CritRevOncog.v16.i1-2.40","article-title":"Myeloid leukemia in Down syndrome","volume":"16","author":"Khan","year":"2011","journal-title":"Crit Rev Oncog"},{"issue":"2","key":"2022102615543322500_B4","first-page":"76","article-title":"Down syndrome and leukemia: insights into leukemogenesis and translational targets","volume":"4","author":"Mateos","year":"2015","journal-title":"Transl Pediatr"},{"issue":"5","key":"2022102615543322500_B5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11899-016-0338-x","article-title":"Transient abnormal myelopoiesis and AML in Down syndrome: an update","volume":"11","author":"Bhatnagar","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"5","key":"2022102615543322500_B6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.pap.0000213039.93328.44","article-title":"Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome","volume":"13","author":"Brink","year":"2006","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"2022102615543322500_B7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ped.13776","article-title":"Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome","volume":"61","author":"Watanabe","year":"2019","journal-title":"Pediatr Int (Roma)"},{"issue":"2","key":"2022102615543322500_B8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bjh.15390","article-title":"Guidelines for the investigation and management of transient leukaemia of Down syndrome","volume":"182","author":"Tunstall","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"2022102615543322500_B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2009.07789.x","article-title":"Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis","volume":"147","author":"Roy","year":"2009","journal-title":"Br J Haematol"},{"issue":"2","key":"2022102615543322500_B10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1542\/peds.2011-1605","article-title":"Health supervision for children with Down syndrome","volume":"128","author":"Bull","year":"2011","journal-title":"Pediatrics"},{"issue":"7","key":"2022102615543322500_B11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/pd.1738","article-title":"Four cases of fetal hypoechoic hepatomegaly associated with Trisomy 21 and transient abnormal myelopoiesis","volume":"27","author":"Kikuchi","year":"2007","journal-title":"Prenat Diagn"},{"issue":"3","key":"2022102615543322500_B12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/uog.17545","article-title":"Prenatal diagnosis of transient abnormal myelopoiesis in three fetuses with Down syndrome: heterogeneous ultrasonographic findings and outcomes","volume":"51","author":"Rizzo","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"22","key":"2022102615543322500_B13","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1182\/blood-2010-05-282426","article-title":"Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia","volume":"116","author":"Kanezaki","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2022102615543322500_B14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ajcp\/aqy001","article-title":"Loss of full-length GATA1 expression in megakaryocytes is a sensitive and specific immunohistochemical marker for the diagnosis of myeloid proliferative disorder related to Down syndrome","volume":"149","author":"Lee","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2022102615543322500_B15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrc2348","article-title":"GATA1-related leukaemias","volume":"8","author":"Shimizu","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2022102615543322500_B16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood-2015-05-567859","article-title":"The biology of pediatric acute megakaryoblastic leukemia","volume":"126","author":"Gruber","year":"2015","journal-title":"Blood"},{"issue":"26","key":"2022102615543322500_B17","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","article-title":"Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children\u2019s Oncology Group Study A2971","volume":"118","author":"Gamis","year":"2011","journal-title":"Blood"},{"issue":"13","key":"2022102615543322500_B18","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/bloodadvances.2018018945","article-title":"Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study","volume":"2","author":"Flasinski","year":"2018","journal-title":"Blood Adv"},{"key":"2022102615543322500_B19","unstructured":"Hitzler\n              J\n            , GarrausM. Transient myeloproliferative disorder of Down syndrome. UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/transient-myeloproliferative-disorder-of-down-syndrome. Accessed January 25 2021, 2021."},{"issue":"12","key":"2022102615543322500_B20","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children\u2019s Oncology Group (COG) study POG-9481","volume":"107","author":"Massey","year":"2006","journal-title":"Blood"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/43\/10\/582\/1387779\/pedsinreview.2021005020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/43\/10\/582\/1387779\/pedsinreview.2021005020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:54:57Z","timestamp":1666799697000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/43\/10\/582\/189515\/Leukocytosis-in-the-Newborn"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,1]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.2021-005020","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"type":"print","value":"0191-9601"},{"type":"electronic","value":"1526-3347"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}